版本:
中国

BRIEF-Cellect gets green light from FDA for ApoGraft IND submission

May 3 Cellect Biotechnology Ltd

* Cellect gets green light from FDA for ApoGraft IND submission in the U.S.

* Cellect biotechnology - U.S. FDA provided Cellect with pre-investigational new drug meeting minutes supporting an IND submission in U.S. for ApoGraft

* Cellect Biotechnology Ltd- submission review included manufacturing (cmc) aspects, pre-clinical data and scope and design of future clinical program. Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐